“…Interestingly, a recent report by Kovacs and colleagues indicates that IL-2 therapy also induces an increased expression of its receptor, CD25, on CD4 ϩ T cells (32a), perhaps suggesting a role for exogenous IL-2 in increasing the T-cell responsiveness to suboptimal levels of endogenous cytokine. However, in the clinical setting it is difficult to assess if there is an additional in vivo antiapoptotic effect of IL-2 as opposed to highly active antiretroviral therapy (HAART) alone (2,5,13,46), given the fact that HAART itself induces a striking reduction of the HIV-induced hyperimmune activation and apoptosis (4,7,29). It is therefore still difficult, at this time, to determine to what extent the intrinsic defect of the endogenous IL-2 autocrine and paracrine function is directly responsible in vivo for the observed cell cycle perturbation.…”